Company / Tangible Book Value per Share
Pfizer Tangible Book Value per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Tangible Book Value per Share
$2.66
FY2025
5-year range
$2.66 / $8.25
FY2021-FY2025
Trend
-22.4%
vs FY2024
Sector context
#133 of 209
Health Care
What the data says
At $2.66, Pfizer's tangible book value per share ranks #133 of 209 in the Health Care sector. Tangible Book Value per Share has declined for 3 consecutive years, from $8.25 in FY2022 to $2.66 in FY2025.
Based on SEC 10-K filings.
2.66 in FY2025 with a 5-year CAGR of +3.1%.
Declined from $6.59 to $2.66 over the past 2 years.
Health Care sector context is included.
Tangible Book Value per Share over time
Growth rates
- 3-Year CAGR
- -31.4%
- 5-Year CAGR
- +3.1%
- 10-Year CAGR
- -
Sector benchmark
#133 of 209 in Health CareTop 64% of 209This company $2.66 Sector average $93.47
▼
-97.1% below sector average
Key checks
Key Insights
- Pfizer's tangible book value per share has declined for 3 consecutive years.
- In FY2025, tangible book value per share decreased 22.4% year-over-year.
- Ranks #133 out of 209 companies in the Health Care sector.
- Peak tangible book value per share was recorded in FY2022.
Company context
Key Data Points
- Altman Z-Score 1.09 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Tangible Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.66 | -22.4% |
| FY2024 | $3.43 | -48.0% |
| FY2023 | $6.59 | -20.1% |
| FY2022 | $8.25 | +69.3% |
| FY2021 | $4.87 | +112.8% |
| FY2020 | $2.29 | -7.3% |
| FY2019 | $2.47 | +104.0% |
| FY2018 | $1.21 | -55.1% |
| FY2017 | $2.69 | +53.1% |
| FY2016 | $1.76 | -26.4% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026